YS Biopharma Shares Rise 9% After Patent Granted for HBV Vaccine

By Chris Wack YS Biopharma shares were up 9% to $1 after the company said Friday that the U.S. Patent and Trademark Office has issued it a patent covering...

Related Keywords

Chris Wack ,Trademark Office ,Investigational New Drug ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Vaccines ,Healthcare Life Sciences ,Biopharmaceuticals ,Specialized Drugs Medications ,Patents ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Intellectual Property Rights ,Industrial Property Rights ,Political General News ,Health ,Hepatitis ,Immunizations ,Medical Conditions ,Infectious Diseases ,Medical Treatments Procedures ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Ys Biopharma ,Ways ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Political ,General News ,Medical Treatments ,Procedures ,Commodity ,Financial Market News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,